Proteosome-Lipopeptide Vaccines: Enhancement of Immunogenicity for Malaria CS Peptides
- 6 May 1988
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 240 (4853) , 800-802
- https://doi.org/10.1126/science.2452484
Abstract
Proteosomes are hydrophobic, membranous, multimolecular preparations of meningococcal outer membrane proteins that are also B cell mitogens. These characteristics suggested that proteosomes may serve as carrier proteins and adjuvants to enhance peptide immunogenicity. Although high titers of malaria circumsporozoite (CS) antibodies protect against malaria, vaccines thus far tested in humans have been insufficiently immunogenic to be clinically useful. Here it is shown that synthetic CS peptides hydrophobically complexed to proteosomes by way of lauroyl-cysteine become highly immunogenic in mice without other adjuvants. The high titers of antibodies produced and the safety of proteosomes in humans suggest that this novel system is widely applicable for the development of peptide vaccines to protect against many diseases.This publication has 25 references indexed in Scilit:
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Construction of Synthetic Immunogen: Use of New T-Helper Epitope on Malaria Circumsporozoite ProteinScience, 1987
- Rationale for Development of a Synthetic Vaccine Against Plasmodium falciparum MalariaScience, 1985
- Immunogenicity of Synthetic Peptides from Circumsporozoite Protein of Plasmodium falciparumScience, 1985
- Expression of Plasmodium falciparum Circumsporozoite Proteins in Escherichia coli for Potential Use in a Human Malaria VaccineScience, 1985
- Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae.The Journal of Experimental Medicine, 1984
- Immunomodulating activity of meningococcal antigensCanadian Journal of Microbiology, 1983
- SYNTHETIC PEPTIDE IMMUNOGENS AS VACCINESAnnual Review of Microbiology, 1983
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979
- Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS.The Journal of Experimental Medicine, 1976